Jim Mahoney


Jim Mahoney serves as the Chairman of the Board of Directors for Novolyze.  Throughout his career, Mr. Mahoney has established a track record of driving new innovations in life sciences and chemistry into high-growth markets. He has over 30 years of senior executive experience at various biotechnology, healthcare and specialty chemicals companies.  He currently serves as Chief Executive Officer of  Vigeo Therapeutics, Inc. Previously, he was an Operating Partner at Ara Partners, a private equity investment firm.  Prior to that he served as CEO and President at Novomer Inc., Surface Logix Inc., and Prolinx Inc. and was a founding senior executive at Dade Behring Inc.  Earlier, he held executive positions at Baxter International and FMC Corporation. Mr. Mahoney received his BS degree from the University of Massachusetts, Amherst, and holds an MBA from Northwestern University’s J.L. Kellogg School of Management and an MMA in international economics from the University of Southern California.